Comparison of Effectiveness and Safety of Ustekinumab and Adalimumab As Induction or Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis

This meta-analysis has been conducted to compare ustekinumab and adalimumab as induction or maintenance therapy in patients with moderate to severe Crohn's disease (CD). The current meta-analysis was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chenna, Venkata Sai Harshabhargav, Nagi, Talwinder K, Suarez, Zoilo K, Hernandez, Oscar L, Nageye, Maymona E, Reyaz, Nafisa, Reyaz, Ibrahim, Ali, Neelum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226155/
https://www.ncbi.nlm.nih.gov/pubmed/37255887
http://dx.doi.org/10.7759/cureus.38277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226155/
https://www.ncbi.nlm.nih.gov/pubmed/37255887
http://dx.doi.org/10.7759/cureus.38277

Ejemplares similares